BACKGROUND AND PURPOSE:Quality of life (QOL) and sleepiness for patients with sleep apnea/hypopnea syndrome (SAHS) might improve with continuous positive airway pressure devices working in auto-adjust mode (autoCPAP) by allowing pressure modulations following patient needs. Clinical comparisons between devices driven by different algorithms are needed. METHODS: We compared the clinical effectiveness of fixed pressure CPAP and four different autoCPAP devices by assessing compliance and QOL (36-item short-form health survey [SF-36]). SAHS patients were randomly allocated to five groups. Polysomnography (PSG) was performed to titrate the effective pressure in the constant CPAP group and evaluate residual apnea/hypopnea index (AHI) under autoCPAP. Follow-up consisted of clinical visits at three and six months by homecare technicians who assessed compliance, symptom scores and SF-36 scores. A laboratory-based PSG using the same CPAP/autoCPAP device as at home was performed at six months. RESULTS:Eighty-three patients (mean age 56+/-10 yrs) with mean body mass index (BMI) 30.8+/-5.3 kg/m(2) and severe SAHS (mean AHI: 52.3+/-17.8/h) were included. There were no differences in clinical symptoms or QOL scores, and similar clinical and PSG improvements were seen in all groups. CPAP use was >5 h per night, without any significant difference between groups. CONCLUSIONS:AutoCPAP is equally as effective as fixed CPAP for long-term home treatment in severe SAHS patients.
RCT Entities:
BACKGROUND AND PURPOSE: Quality of life (QOL) and sleepiness for patients with sleep apnea/hypopnea syndrome (SAHS) might improve with continuous positive airway pressure devices working in auto-adjust mode (autoCPAP) by allowing pressure modulations following patient needs. Clinical comparisons between devices driven by different algorithms are needed. METHODS: We compared the clinical effectiveness of fixed pressure CPAP and four different autoCPAP devices by assessing compliance and QOL (36-item short-form health survey [SF-36]). SAHS patients were randomly allocated to five groups. Polysomnography (PSG) was performed to titrate the effective pressure in the constant CPAP group and evaluate residual apnea/hypopnea index (AHI) under autoCPAP. Follow-up consisted of clinical visits at three and six months by homecare technicians who assessed compliance, symptom scores and SF-36 scores. A laboratory-based PSG using the same CPAP/autoCPAP device as at home was performed at six months. RESULTS: Eighty-three patients (mean age 56+/-10 yrs) with mean body mass index (BMI) 30.8+/-5.3 kg/m(2) and severe SAHS (mean AHI: 52.3+/-17.8/h) were included. There were no differences in clinical symptoms or QOL scores, and similar clinical and PSG improvements were seen in all groups. CPAP use was >5 h per night, without any significant difference between groups. CONCLUSIONS: AutoCPAP is equally as effective as fixed CPAP for long-term home treatment in severe SAHS patients.
Authors: Susheel P Patil; Indu A Ayappa; Sean M Caples; R Joh Kimoff; Sanjay R Patel; Christopher G Harrod Journal: J Clin Sleep Med Date: 2019-02-15 Impact factor: 4.062
Authors: George C Dungan; Nathaniel S Marshall; Camilla M Hoyos; Brendon J Yee; Ronald R Grunstein Journal: J Clin Sleep Med Date: 2011-06-15 Impact factor: 4.062
Authors: Alexandra Valentin; Shyam Subramanian; Stuart F Quan; Richard B Berry; Sairam Parthasarathy Journal: Sleep Date: 2011-06-01 Impact factor: 5.849
Authors: Surendra K Sharma; Vishwa Mohan Katoch; Alladi Mohan; T Kadhiravan; A Elavarasi; R Ragesh; Neeraj Nischal; Prayas Sethi; D Behera; Manvir Bhatia; A G Ghoshal; Dipti Gothi; Jyotsna Joshi; M S Kanwar; O P Kharbanda; Suresh Kumar; P R Mohapatra; B N Mallick; Ravindra Mehta; Rajendra Prasad; S C Sharma; Kapil Sikka; Sandeep Aggarwal; Garima Shukla; J C Suri; B Vengamma; Ashoo Grover; V K Vijayan; N Ramakrishnan; Rasik Gupta Journal: Lung India Date: 2015 Jul-Aug
Authors: Stanley Ip; Carolyn D'Ambrosio; Kamal Patel; Ndidiamaka Obadan; Georgios D Kitsios; Mei Chung; Ethan M Balk Journal: Syst Rev Date: 2012-03-08